HCV - HepNet - Dr. Howard Worman - Host genetic factors influence disease

HepNet - Dr. Howard Worman - Host genetic factors influence disease
Host genetic factors influence disease progression in chronic hepatitis C By Howard J. Worman, M. D. Powell, E. E., Edwards-Smith, C. J., Hay, J. L., Clouston, A

Hepatitis C Advocacy : : Hepatitis C
Chronic hepatitis C For those who do not clear the virus within 6 months, Hepatitis C infection progresses to a second phase: chronic infection. During the chronic phase few people have symptoms

FDA Approves New Chronic Hepatitis C Treatment
FDA Approves New Chronic Hepatitis C Treatment FDA has approved a drug/biologic combination to treat chronic hepatitis C in patients with compensated liver disease who have relapsed following

The Body: Chronic Hepatitis C: Current Disease Management
Chronic Hepatitis C: Current Disease Management, at The Body, the complete HIV/AIDS resource.

Sloan-Kettering - Find a Clinical Trial
Phase II Study of Sho-saiko-to in Patients with Chronic Hepatitis C Who Cannot Use Interferon [Protocol 02-073]